The burgeoning weed industry stands poised for explosive growth if the federal government takes the crucial step of rescheduling cannabis. Currently, its classification as a Schedule I drug creates staggering barriers to research, limits banking and investment options, and perpetuates discriminatory policies. Rescheduling would unlock a "Green Rush